Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do an analysis on Salesforce Stock, Pepsi stock & CNI Stock

3 extracted signals · 3 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor09 Aug 2025, 22:19 UTC
Video preview for Friends! In this video, I'm going to do an analysis on Salesforce Stock, Pepsi stock & CNI Stock
Signals
3
Eligible signals in this source
Open
0
Still being tracked
Resolved
3
Evaluable outcomes
Successful
1
Canonical correct result
Failed
2
Canonical failed result
Resolved success
33.33%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video provides a market analysis focused on three stocks: CRM, PEP, and CNI, with a timeframe of 12 months. Starting with Salesforce (CRM), it notes a 27% year-to-date decrease despite 8% revenue growth and substantial subscription-based revenues, which are also up 8% year-on-year. Trading at 20 times earnings, a contraction from prior levels, CRM is perceived as facing decelerating revenue growth and strong competition. A potential acquisition of Informatica for inorganic revenue growth is mentioned. For PepsiCo (PEP), it highlights an 11% price increase from its low, improvements within PepsiCo and an earnings beat, with management expecting a future contraction in revenue growth, and is known for its ability to raise prices. The target for PEP is set on 160. Canadian National Railway (CNI) has faced struggles due to tariffs, significantly impacting earnings per share growth to just 2%. CNI's connection between Canada and the U.S., reaching New Orleans and Mobile, is noted. The video indicates a lack of revenue growth due to the headwinds that 30% of their revenue is being affected by. This analysis makes a bullish case for PEP and CNI, where the video analysis gives potential targets of 160 and 100, respectively. The presenter notes that CNI might also be bottoming out and is undervalued. A case is made to stay away from CRM, despite the seemingly undervaluation.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    3 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.